TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Pathways mainly include Wnt signalling pathway, Fanconi anaemia pathway, human T‐cell leukaemia virus infection, chronic myeloid leukaemia, colorectal cancer, TGF‐β signalling pathway, MAPK signalling pathway, etc. (Figure 2B).